ATE218323T1 - Pharmazeutische formulierung - Google Patents

Pharmazeutische formulierung

Info

Publication number
ATE218323T1
ATE218323T1 AT97944000T AT97944000T ATE218323T1 AT E218323 T1 ATE218323 T1 AT E218323T1 AT 97944000 T AT97944000 T AT 97944000T AT 97944000 T AT97944000 T AT 97944000T AT E218323 T1 ATE218323 T1 AT E218323T1
Authority
AT
Austria
Prior art keywords
methoxypsoralen
pharmacologically
pharmaceutical formulation
optionally
acceptable
Prior art date
Application number
AT97944000T
Other languages
English (en)
Inventor
Robin Morley
Michael Bedford-Stradling
Original Assignee
Crawford Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crawford Healthcare Ltd filed Critical Crawford Healthcare Ltd
Application granted granted Critical
Publication of ATE218323T1 publication Critical patent/ATE218323T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97944000T 1996-10-15 1997-10-14 Pharmazeutische formulierung ATE218323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9621480A GB2318291B (en) 1996-10-15 1996-10-15 8-Methoxypsoralen containing additives for topical application in bath water
PCT/GB1997/002716 WO1998016195A1 (en) 1996-10-15 1997-10-14 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
ATE218323T1 true ATE218323T1 (de) 2002-06-15

Family

ID=10801451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944000T ATE218323T1 (de) 1996-10-15 1997-10-14 Pharmazeutische formulierung

Country Status (9)

Country Link
EP (1) EP0946139B1 (de)
AT (1) ATE218323T1 (de)
AU (1) AU4564797A (de)
DE (1) DE69713143T2 (de)
DK (1) DK0946139T3 (de)
ES (1) ES2178009T3 (de)
GB (1) GB2318291B (de)
WO (1) WO1998016195A1 (de)
ZA (1) ZA979179B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19927168A1 (de) * 1999-06-15 2000-12-21 Cognis Deutschland Gmbh Ölbäder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445422B (sv) * 1979-06-25 1986-06-23 Gerot Pharmazeutika Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin
CA1173751A (en) * 1980-05-07 1984-09-04 Jack H. Lazarus Methoxsalen dosage forms
US4454152A (en) * 1980-05-07 1984-06-12 Hoffmann-La Roche Inc. Methoxsalen dosage forms
LU85829A1 (fr) * 1985-04-01 1986-11-05 Cird Composition pour bains a base de psoralene dans le traitement du psoriasis
GB9409945D0 (en) * 1994-05-17 1994-07-06 Bioglan Lab Ltd A medicated wipe

Also Published As

Publication number Publication date
ES2178009T3 (es) 2002-12-16
DK0946139T3 (da) 2002-09-23
GB2318291B (en) 1998-09-23
GB2318291A (en) 1998-04-22
EP0946139B1 (de) 2002-06-05
DE69713143D1 (de) 2002-07-11
AU4564797A (en) 1998-05-11
EP0946139A1 (de) 1999-10-06
DE69713143T2 (de) 2003-02-20
ZA979179B (en) 1999-07-14
GB9621480D0 (en) 1996-12-04
WO1998016195A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
ES2175113T3 (es) Composiciones para la provocacion de embolias en vasos sanguineos.
DE60033684D1 (de) Phenylalaninderivate
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
FI990596L (fi) Luun morfogeneettiset proteiini-16 (BMP-16) -koostumukset
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
ES2052809T3 (es) Agente desinfectante tuberculocida.
PT1073467E (pt) Formulacoes de co-solvente que compreendem um composo de vitamina d.
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
ES2088965T3 (es) Derivados de rodanina aril-sustituidos.
NO913035L (no) (2r)-2-(di(2-propyl)fosfonylmetoksy)-3-p-toluensulfonyloksy-1-trimetylacetoksypropan, fremgangsmaate for fremstilling og anvendelse derav.
DE69532809D1 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
DK1169058T3 (da) Insulinlignende vækstfaktorbindingsprotein-4-protease
DE69713143D1 (de) Pharmazeutische formulierung
EP1084710A4 (de) Medikamente gegen männliche sterilität
ATE244024T1 (de) Sterilisationsschutzmittel und verfahren zur sterilisation
ATE205246T1 (de) Molkerei-reinigungssystemverfahren
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
ES2053679T3 (es) Embonato de azelastina, procedimiento para su preparacion y preparados farmaceuticos que contienen embonato de azelastina como principio activo.
ATE306914T1 (de) Wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
FI962725L (fi) Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee